Actionable Real-World Evidence to Improve Health Outcomes and Reduce Medical Spending Among Risk-Stratified Patients with Diabetes.
Garry EM, Schneeweiss S, Eapen S, Petruski-Ivleva N, Cheever E, Murk W, Rajan A, Rassen JA, Gambino D, Jang H, Rubin E, Jan S.
Garry EM, et al. Among authors: jan s.
J Manag Care Spec Pharm. 2019 Dec;25(12):1442-1452. doi: 10.18553/jmcp.2019.25.12.1442.
J Manag Care Spec Pharm. 2019.
PMID: 31778623
Free PMC article.
He is the principal investigator of investigator-initiated grants to the Brigham and Women's Hospital from Bayer, Genentech, Boehringer Ingelheim, and Vertex. ...He was recently appointed to a board observer position at Aetion, as Horizon has small equity interest in Aetio …
He is the principal investigator of investigator-initiated grants to the Brigham and Women's Hospital from Bayer, Genentech, Boehring …